These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1458491

  • 1. Lack of T-cell immunity in humans with preexisting anti-mouse immunoglobulin reactivity.
    Conry RM, Khazaeli MB, LoBuglio AF.
    Cancer Res; 1992 Dec 15; 52(24):6979-82. PubMed ID: 1458491
    [Abstract] [Full Text] [Related]

  • 2. Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors.
    Courtenay-Luck NS, Epenetos AA, Winearls CG, Ritter MA.
    Cancer Res; 1987 Aug 15; 47(16):4520-5. PubMed ID: 2440569
    [Abstract] [Full Text] [Related]

  • 3. Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.
    Tax WJ, Hermes FF, Willems RW, Capel PJ, Koene RA.
    J Immunol; 1984 Sep 15; 133(3):1185-9. PubMed ID: 6235283
    [Abstract] [Full Text] [Related]

  • 4. Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodies.
    Losman MJ, DeJager RL, Monestier M, Sharkey RM, Goldenberg DM.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):1055s-1058s. PubMed ID: 2297721
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin class and immunoglobulin G subclass analysis of human anti-mouse antibody response during monoclonal antibody treatment of cancer patients.
    Blottière HM, Douillard JY, Koprowski H, Steplewski Z.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):1051s-1054s. PubMed ID: 2297720
    [Abstract] [Full Text] [Related]

  • 6. Human immune response to multiple injections of murine monoclonal IgG.
    Shawler DL, Bartholomew RM, Smith LM, Dillman RO.
    J Immunol; 1985 Aug 01; 135(2):1530-5. PubMed ID: 3874237
    [Abstract] [Full Text] [Related]

  • 7. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
    Chatenoud L, Baudrihaye MF, Chkoff N, Kreis H, Goldstein G, Bach JF.
    J Immunol; 1986 Aug 01; 137(3):830-8. PubMed ID: 3487589
    [Abstract] [Full Text] [Related]

  • 8. Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
    Dziarski R.
    J Immunol; 1984 Nov 01; 133(5):2537-44. PubMed ID: 6207235
    [Abstract] [Full Text] [Related]

  • 9. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM, Craddock GR, Warr GW, DeLuca D, Marchalonis JJ.
    J Immunol; 1983 Sep 01; 131(3):1582-90. PubMed ID: 6350458
    [Abstract] [Full Text] [Related]

  • 10. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy.
    Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC.
    Cancer Res; 1985 Feb 01; 45(2):879-85. PubMed ID: 3871353
    [Abstract] [Full Text] [Related]

  • 11. The role of humoral and cellular immunity in patients developing human anti-murine immunoglobulin antibody responses after radioimmunotherapy.
    Kosmas C, Man S, Epenetos AA, Courtenay-Luck NS.
    Br J Cancer Suppl; 1990 Jul 01; 10():85-8. PubMed ID: 2383486
    [Abstract] [Full Text] [Related]

  • 12. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL, Bloemmen FJ, Van Wauwe JP.
    J Immunol; 1985 Dec 01; 135(6):3882-6. PubMed ID: 2933454
    [Abstract] [Full Text] [Related]

  • 13. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R, van Haarlem LJ, Warnaar SO, Holz E, Riethmüller G.
    Cancer Res; 2000 Apr 01; 60(7):1921-6. PubMed ID: 10766181
    [Abstract] [Full Text] [Related]

  • 14. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
    Goldman-Leikin RE, Kaplan EH, Zimmer AM, Kazikiewicz J, Manzel LJ, Rosen ST.
    Exp Hematol; 1988 Nov 01; 16(10):861-4. PubMed ID: 3262528
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B, Golub RM, Nguyen AT, Feuillet-Fieux MN.
    J Immunol; 1983 Nov 01; 131(5):2500-7. PubMed ID: 6195264
    [Abstract] [Full Text] [Related]

  • 16. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
    Demanet C, Brissinck J, Van Mechelen M, Leo O, Thielemans K.
    J Immunol; 1991 Aug 01; 147(3):1091-7. PubMed ID: 1830596
    [Abstract] [Full Text] [Related]

  • 17. Idiotypic specificity of a human monoclonal anti-Rhesus(D) antibody.
    Lambin P, Rouger P, Goossens D, Hérance N, de Saint Martin J, Fine JM, Salmon C.
    Ann Inst Pasteur Immunol; 1986 Aug 01; 137D(3):383-90. PubMed ID: 3030361
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
    Geha RS.
    J Immunol; 1984 Oct 01; 133(4):1846-51. PubMed ID: 6206140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.